SEC Form D · Amendment · filed January 12, 2021
Osteal Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (18)
Douglas Kohrs · San Clemente, CADirectorDavid Cash · San Clemente, CADirectorBrian De Beaubien · San Clemente, CADirectorJude Paganelli · San Clemente, CAExec · DirectorNoam Krantz · San Clemente, CADirectorDavid Thompson · San Clemente, CAExec · DirectorChristopher J. Green · New York, NYDirectorSachin K. Srivastava · New York, NYDirectorThomas Casten · Hinsdale, ILExec · DirectorAdam I. Gunasekara · New York, NYDirectorSaurabh K. Srivastava · New York, NYDirectorShanta E. Puchtler · New York, NYExec · DirectorJeffrey Glass · Boston, MADirectorAndris Kikauka · Sooke, British Columbia, CanadaExec · DirectorLarry Reaugh · Surrey, British Columbia, CanadaDirectorEdward Skoda · Chapala, O5DirectorShaheem Ali · Surrey, British Columbia, CanadaDirectorNorman Tribe · Kelowna, British Columbia, CanadaExec · Director Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗